Clinical Trials Browser

Phase 2 × Glioblastoma × GC1118 × Clear all

NCT03618667 2023-05-12

GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification

Phase 2 Completed

Glioblastoma